Giuseppe Lombardi/.pugliaeccellente.info
Mar 17, 2024, 13:22
Lombardi Giuseppe: Prospective study on regorafenib in recurrent glioblastoma
Lombardi Giuseppe, Head of the Neuro-Oncology Unit at the Veneto Institute of Oncology, shared on X:
“Finally out!! 30 Italian centers and 190 patients enrolled: what an incredible effort for this prospective study on regorafenib in recurrent glioblastoma! Thanks to all of the collaborators!!”
Proceed to the article.
Source: Lombardi Giuseppe/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 20, 2025, 02:27
Apr 19, 2025, 22:24
Apr 19, 2025, 22:03
Apr 19, 2025, 21:39
Apr 19, 2025, 21:21
Apr 19, 2025, 21:04
Apr 19, 2025, 20:48
Apr 19, 2025, 20:25
Apr 19, 2025, 19:36
Apr 19, 2025, 19:17